Neo-Adjuvant immunotherapies: Bladder cancer as a platform for drug development targeting mucosal immunity. Chung R, McKiernan J, Arpaia N, Marabelle A, et al. Eur J Cancer 2023;187:58-64.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Chung R, McKiernan J, Arpaia N, Marabelle A, et al. Neo-Adjuvant immunotherapies: Bladder cancer as a platform for drug development targeting mucosal immunity. Eur J Cancer 2023;187:58-64.
PMID: 37116288